Literature DB >> 833937

Use of specific radioactive probes to study transcription and replication of the influenza virus genome.

J M Taylor, R Illmensee, S Litwin, L Herring, B Broni, R M Krug.   

Abstract

Specific radioactive probes have been obtained for both influenza virion RNA (vRNA) and for its complement (complementary RNA or cRNA): 32P-labeled complementary DNA (cDNA) synthesized with the avian sarcoma virus reverse transcriptase, and [125I]vRNA, respectively. From the kinetics of annealing of these two probes to RNA from canine kidney cells infected with the WSN strain of influenza virus, we have determined the average number of cRNA and vRNA sequences in the nucleus and cytoplasm as a function of time after infection. Immediately after infection, a small amount of vRNA is detected, presumably from the inoculum virus. As expected, the amount of cRNA is insignificant. During the first 1.75 h of infection, the most significant increase observed is in cRNA sequences. Most of these cRNA sequences are found in the cytoplasm, but a significant amount (30%) is found in the nucleus. During this time, a small but significant increase in vRNA is also detected in the nucleus and cytoplasm. From 1.75 to 2.75 h, the absolute amounts of both cRNA and vRNA increase, predominantly in the cytoplasm, with cRNA remaining as the majority species. Subsequently, the amount of vRNA increases with respect to cRNA and becomes the majority species. At 3.75 h, 95% of both cRNA and vRNA are found in the cytoplasm. Addition of actinomycin D at 1.75 h completely suppresses the subsequent ninefold increase in cRNA and does not have a significant effect on the subsequent 14-fold increase in cytoplasmic vRNA. This assay is also able to detect the cRNA produced as a result of primary transcription, operationally defined as the cRNA produced in the presence of 100 mug of cycloheximide per ml added at zero time of infection. Increases in cRNA in the presence of cycloheximide are detectable in both the nucleus and the cytoplasm. Addition of actinomycin D as well as cycloheximide at zero time completely suppresses the appearance of cRNA in the cytoplasm, whereas a large fraction (50%) of the increase in nuclear cRNA still occurs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833937      PMCID: PMC353854          DOI: 10.1128/JVI.21.2.530-540.1977

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  DELAY IN THE MULTIPLICATION OF INFLUENZA VIRUS.

Authors:  D O WHITE; H M DAY; E J BATCHELDER; I M CHEYNE; A J WANSBROUGH
Journal:  Virology       Date:  1965-02       Impact factor: 3.616

2.  Synethesis and integration of viral DNA in chicken cells at different time after infection with various multiplicities of avian oncornavirus.

Authors:  A T Khoury; H Hanafusa
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

3.  Polyadenylate sequences of fowl plague virus complementary RNA (cRNA) synthesized in vivo and in vitro.

Authors:  Y Ghendon; O Blagoveshienskaya
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

4.  Characterization of Novikoff hepatoma mRNA methylation and heterogeneity in the methylated 5' terminus.

Authors:  R C Desrosiers; K H Friderici; F M Rottman
Journal:  Biochemistry       Date:  1975-10-07       Impact factor: 3.162

5.  Methylated simian virus 40-specific RNA from nuclei and cytoplasm of infected BSC-1 cells.

Authors:  S Lavi; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

6.  Hybridization of 125I-labeled ribonucleic acid.

Authors:  A Tereba; B J McCarthy
Journal:  Biochemistry       Date:  1973-11-06       Impact factor: 3.162

7.  The inhibition of influenza virus RNA synthesis by actinomycin D and cycloheximide.

Authors:  M W Pons
Journal:  Virology       Date:  1973-01       Impact factor: 3.616

8.  Primary transcription of the influenza virus genome in permissive cells.

Authors:  W J Bean; R W Simpson
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

9.  Cytoplasmic and nucleoplasmic viral RNPs in influenza virus-infected MDCK cells.

Authors:  R M Krug
Journal:  Virology       Date:  1972-10       Impact factor: 3.616

10.  Effect of actinomycin D on the replication of influenza virus and influenza virus RNA.

Authors:  M Pons
Journal:  Virology       Date:  1967-09       Impact factor: 3.616

View more
  19 in total

1.  Model suggesting that replication of influenza virus is regulated by stabilization of replicative intermediates.

Authors:  Frank T Vreede; Tanis E Jung; George G Brownlee
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Regulation of influenza RNA polymerase activity and the switch between replication and transcription by the concentrations of the vRNA 5' end, the cap source, and the polymerase.

Authors:  Andrew C Olson; Eric Rosenblum; Robert D Kuchta
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

3.  The R35 residue of the influenza A virus NS1 protein has minimal effects on nuclear localization but alters virus replication through disrupting protein dimerization.

Authors:  Erin N Lalime; Andrew Pekosz
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

4.  Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro.

Authors:  S J Plotch; M Bouloy; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

5.  A small-RNA enhancer of viral polymerase activity.

Authors:  Jasmine T Perez; Ivan Zlatev; Shilpa Aggarwal; Sailakshmi Subramanian; Ravi Sachidanandam; Baek Kim; Muthiah Manoharan; Benjamin R tenOever
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

6.  Use of specific single stranded DNA probes cloned in M13 to study the RNA synthesis of four temperature-sensitive mutants of HK/68 influenza virus.

Authors:  F Thierry; O Danos
Journal:  Nucleic Acids Res       Date:  1982-05-11       Impact factor: 16.971

7.  Segments of influenza virus complementary RNA synthesized in vitro.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

8.  Influenza virus-specific RNA and protein syntheses in cells infected with temperature-sensitive mutants defective in the genome segment encoding nonstructural proteins.

Authors:  A J Wolstenholme; T Barrett; S T Nichol; B W Mahy
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

9.  Nuclear accumulation of influenza viral RNA transcripts and the effects of cycloheximide, actinomycin D, and alpha-amanitin.

Authors:  G E Mark; J M Taylor; B Broni; R M Krug
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

10.  Interferon-induced Sus scrofa Mx1 blocks endocytic traffic of incoming influenza A virus particles.

Authors:  Mélanie Palm; Mutien-Marie Garigliany; François Cornet; Daniel Desmecht
Journal:  Vet Res       Date:  2010-01-13       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.